Sandalan, Rhianne .
HRN: 16-25-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2023
CEFUROXIME 750MG (VIAL)
06/27/2023
07/04/2023
IV
500mg
Q8
PCAP
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes